Condition

Small Cell Lung Cancer Limited Stage

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 13 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13
Recruiting3
Common interventions24
Lead sponsors shown11
Advertisement

Clinical trials

13 shown
Durvalumab as Consolidation for Patients LS-SCLCNCT07055581 · 2026-02-24
RECRUITING
A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung CancerNCT06483282 · 2024-06-21
RECRUITING
Molecular Analysis and Treatment Options of SCLCNCT05945745 · 2016-01-01
RECRUITING
A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer PatientsNCT06469879 · 2024-09-01
UNKNOWN
PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC PatientsNCT05651802 · 2023-01-01
UNKNOWN
Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung CancerNCT04882033 · 2021-05-07
UNKNOWN
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)NCT04602533 · 2020-12-21
ACTIVE_NOT_RECRUITING
Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent ChemoradiotherapyNCT04418648 · 2020-06-01
TERMINATED
Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLCNCT04189094 · 2020-01-01
UNKNOWN
A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLCNCT04543890 · 2018-05-01
UNKNOWN
Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLCNCT03214003 · 2017-06-30
COMPLETED
Immunotherapy as Second-line in Patient With Small Cell Lung CancerNCT03059667 · 2017-03-13
COMPLETED
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung CancerNCT01797159 · 2013-03-11
COMPLETED

Common interventions

Trial status mix

UNKNOWN5
COMPLETED3
RECRUITING3
ACTIVE_NOT_RECRUITING1
TERMINATED1

Phase mix

PHASE27
NA3
PHASE11
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.